Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients (ProCOVRA)

University Hospital Center (CHU)

Status: Completed

Conditions: Covid19; Rheumatoid Arthritis

Study type: Observational

Funder types: Other

Identifiers

NCT04679272

RECHMPL20_0682

Details and patient eligibility

About

COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.

Enrollment: 2,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed COVID-19 diagnosis (positive PCR or serology) in RA patients or healthy controls.

Exclusion criteria

• Age under 18 years old
• Suspected COVID-19 diagnosis (typical symptoms without a positive PCR or serology)